Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of ...
New data confirm similar response rates with fewer toxicities when carboplatin is dropped from standard neoadjuvant therapy in early HER2-positive breast cancer.
The European regulator recommends granting pediatric use marketing authorization for Bopediat to treat children with oedema ...
At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic ...
A review of published studies suggests that skin toxicities related to checkpoint inhibitors may be managed differently in ...
DENVER — A pair of new studies highlight the mental health toll of alopecia areata (AA): Black women with the condition are ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that Tecovirimat SIGA ...
A population-based, prospective cohort study conducted in China finds that lung cancer risk remains low until 3 years after a negative low-dose CT screen.
Drs Bob Harrington and Bob Wachter discuss the use of AI in healthcare, and Dr Wachter’s latest book, A Giant Leap.
Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions for two drugs for the treatment of adults ...
Low preoperative grip strength can be a useful screening tool for predicting postoperative loss of independence in older adults undergoing hepatobiliary-pancreatic surgery.
Marne-cel now offers an option to children with the rare immune disorder who lack a sibling donor for stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results